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ABSTRACT
Trichosporonosis is an emerging, life-threatening opportunistic pathogen, implicated in superficial and mucosal infections. However, 
systemic infections are known to occur in immunocompromised conditions like cancer, burns, transplant patients as well as patients 
on steroids, peritoneal dialysis, prolonged mechanical ventilation and those undergoing prosthetic valve surgeries. Here, we report the 
case of Trichosporon asahii isolated from the urine sample of a 69-year-old male patient presented with septic shock. Early diagnosis 
and management of trichosporonosis which mimic disseminated candidiasis will reduce the mortality rate by selecting appropriate 
antimicrobial therapy.
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Trichosporonosis is an emerging infection of immunocompromised host predominantly caused by Trichosporon asahii which is a ubiquitous anamorphic 
yeast [1,2]. Trichosporon spp as a part of normal flora of the skin 
and respiratory tract, isolated as a causative agent of superficial 
and deep fungal infections. Systemic infections are known in 
immunocompromised conditions like cancer, burns, transplant 
patients, patients on steroids, peritoneal dialysis, prolonged 
mechanical ventilation and those undergoing prosthetic valve 
surgeries [3,4].
Till now, only a few case reports of disseminated 
trichosporonosis been reported from various parts of India but 
there is no exact information on the incidence of disseminated 
trichosporonosis [5-7]. Globally, the majority of the cases 
of trichosporonosis and geotrichosis were reported in North 
American medical centers (33.9%), followed by medical centers 
from Europe (27.6%) and Asia (23.3%). In another study, 
trichosporonemia reported in 74.7% of patients and disseminated 
infection in 50.6% of cases, which appears relatively high [8]. A 
Study done by Chitasombat et al [9] has estimated an increase 
in the incidence of invasive yeast infections by Trichosporon 
spp, which accounts for 20%. We report the case of Trichosporon 
asahii isolated from an immunocompromised patient presented 
with urosepsis in a tertiary care centre.
CASE REPORT
A 69-year-old male patient admitted to the hospital with 
complaints of fever, edema, and oliguria. The patient was a 
known case of chronic kidney disease since 6 years along with 
multiple underlying comorbidities such as type 2 diabetes 
mellitus, hypertension, acute coronary syndrome and history of 
cardiac arrest which was successfully resuscitated. 
On examination, the patient was vitally stable. During the 
course of stay in the hospital, the patient was intubated and 
was on a mechanical ventilator. Hemodialysis was initiated and 
continued. Blood, urine and endotracheal aspirate were sent for 
bacterial, fungal culture and sensitivity. 
In view of persistent fever and septicemia, the patient 
was started on Fosfomycin, Polymyxin B and Caspofungin 
empirically for 10 days. The urine sample was inoculated with a 
standard loop on Cysteine lactose electrolyte deficient agar and 
Sabouraud’s dextrose agar and incubated at both 370C and 220C, 
which showed significant growth of dry creamy white colonies 
after overnight incubation (Fig. 1). Gram stain and lactophenol 
cotton blue mount revealed hyaline septate hyphae with 
arthroconidia and few budding yeast cells were also seen (Fig. 2). 
In Corn meal agar, arthroconidia was seen. Budding yeast cell 
with hyaline septate hyphae, negative germ tube test, positive 
urease test and arthroconidia in Corn Meal test were suspected as 
Trichosporon spp. Following which the isolates were identified 
to be Trichosporon asahii by hydrolysis of urea, fermentation 
of sugars and further confirmation was done by MALDI-TOF. 
Antifungal susceptibility was done in Muller Hinton Agar 
supplemented with 2% glucose and methylene blue by E-test 
(HiMedia laboratories, India) for fluconazole, itraconazole, 
voriconazole, amphotericin B and caspofungin. The organism 
appeared sensitive to voriconazole with minimal inhibitory 
concentration (MIC) of0.094 µg/ml and was found to be resistant 
to other antifungal agents like amphotericin B, fluconazole, 
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itraconazole, and caspofungin. The patient was advised for repeat 
sample to confirm pathogen and to rule out contaminant, which 
again showed a similar picture of growth and sensitivity as that 
of the first sample. Blood culture was sterile and in endotracheal 
aspirate, Acinetobacter baumaniiwas isolated which was sensitive 
only to Polymyxin B. In view of culture report, Inj Caspofungin 
was stopped and the patient was started on voriconazole and 
polymyxin B. Though the patient recovered slowly, subsequent 
urine cultures turned out to be sterile and because of multiple 
underlying comorbidities, the patient suddenly developed another 
episode of cardiac arrest and could not be revived.
DISCUSSION
Trichosporon spp is an opportunistic fungal pathogen 
which has recently emerged as a significant problem in 
immunocompromised hosts. In our case, we have isolated T. 
asahii from the urine sample of an immunocompromised patient 
with an indwelling catheter who was on treatment for multiple 
comorbidities. T. asahii which was identified phenotypically 
was further confirmed by an automated system. Antifungal 
susceptibility done by E-test revealed multidrug resistance 
with preserved susceptibility only to voriconazole. Broadly, 
Trichosporonosis refers to superficial and deep infections 
caused by genus Trichosporon. Superficial infections include 
white piedra (hair shaft), onychomycosis and otomycosis, 
and invasive infection. Invasive infection can be further 
divided into localized deep tissue infection and disseminated 
(hematogenous) infection. The most frequently affected organ 
is the lungs, representing approximately 33% of localized deep 
tissue infections [10].
The major pathogen responsible for invasive infection is 
Trichosporon asahii. Trichosporon species grow as yeast-like 
colonies in vitro; in vivo, however, hyphae, pseudohyphae, and 
arthroconidia can also be seen. Systemic infection occurs almost 
exclusively in immunocompromised hosts, including those who 
have hematologic malignancies, are neutropenic, have received a 
solid organ transplant, or are receiving glucocorticoids [11]. Renal 
involvement in disseminated infection is quite common and occurs 
in 75% of the cases. Urine cultures positive for Trichosporon 
spp suggests disseminated disease in a neutropenic patient. On 
Sabouraud dextrose agar, T. asahii grows readily showing smooth, 
shiny gray to cream-colored yeast-like colonies with radiating 
furrows that become dry and membranous with age [12].
Rates of response to Amphotericin B have been disappointing, 
and many Trichosporon spp are resistant in vitro. Voriconazole 
appears to be the antifungal agent of choice and is used at a 
dosage of 200–400 mg twice daily. The mortality rates for 
disseminated infections due to Trichosporon spp have been as 
high as 70% but should decrease with the use of newer azoles, 
such as voriconazole, however, patients who remain neutropenic 
are likely to succumb to this infection [11].
CONCLUSION
A high index of clinical and microbiological suspicion is required 
for an optimal diagnosis of infections due to Trichosporon spp 
for further management. Presence of multiple comorbidities 
with variable clinical response and administration of multiple 
antimicrobials would further complicate the prognosis of the 
patient. Early diagnosis and management of Trichosporonosis 
which mimic disseminated candidiasis will reduce the mortality 
rate by selecting appropriate antimicrobial therapy.
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